CLINICAL_TRIALS
trial_result
· 2023-11-02
Clinical Trial Update: Efficacy and Safety of Sirolimus in LAM [Phase 3]
Summary
Phase 3 clinical trial assessing efficacy and safety of sirolimus in lymphangioleiomyomatosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Cincinnati | Conditions: Lymphangioleiomyomatosis | Phase 3 | Status: COMPLETED | Results posted: 2023-11-02